A 3-week, open label study to evaluate the efficacy and safety of extended release quetiapine fumarate in the treatment of agitation in patients with schizophrenia
Koh Hui, Ahmad Sulaiman, Jesjeet Singh, Subash Kumar, Stephen Thevanathan, Rusdi Rashid
( Psychiatry and Clinical Psychopharmacology 2013; 23: 14-23) DOI: 10.5455/bcp.20130127022922